Order Article Reprints

Wang Y, Shi G, Wang X, Xie Z, Gou J, Huang L, Huang H, You W, Wang R, Yang Y, et al. Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18–49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study. Vaccines. 2024; 12(8):827. https://doi.org/10.3390/vaccines12080827

Wang, Yanxia, Gang Shi, Xue Wang, Zhiqiang Xie, Jinbo Gou, Lili Huang, Haitao Huang, Wangyang You, Ruijie Wang, Yongli Yang, and et al. 2024. "Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18–49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study" Vaccines 12, no. 8: 827. https://doi.org/10.3390/vaccines12080827

Wang, Y., Shi, G., Wang, X., Xie, Z., Gou, J., Huang, L., Huang, H., You, W., Wang, R., Yang, Y., Wang, F., Zhu, T., & Zhao, D. (2024). Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18–49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study. Vaccines, 12(8), 827. https://doi.org/10.3390/vaccines12080827